III

Scott G Tilden1, Madison H Ricco1, Emily A Hemann2

  • 1University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO.

概括

第三类干扰素 (IFN-λ) 预治疗增强了纳米医药瘤积累和疗效. 这种方法通过在临床前模型中增加生存时间来改善抗癌治疗.